Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite some positive aspects, such as increased business with Lowe's and a stable EMEA region, the overall sentiment is negative. The earnings call reveals significant challenges, including declining revenues across most regions, gross margin deterioration, and increased litigation risks. The Q&A session confirmed these concerns without providing mitigating factors. Additionally, the impact of new U.S. tariffs and ongoing silicosis-related lawsuits further contribute to a negative outlook. The company's financial health is strained, as evidenced by the adjusted EBITDA loss and increased net loss per share, making a negative stock price reaction likely.
Global Revenue $101.1 million, down 15.6% year-over-year on a constant currency basis due to lower volumes resulting from continued global economic headwinds and competitive pressures.
U.S. Sales $49.6 million, declined by 17% year-over-year, mainly reflecting softer market conditions in the residential channel and challenges in the commercial segment. However, business with Lowe's increased in double-digit percentages compared to the second quarter of 2024.
Australia Sales Declined by 18.2% on a constant currency basis, reflecting shifts following the government silica ban effective July 1, 2024, combined with slower demand due to high interest rates and fewer new home completions.
Canada Sales Decreased by 12.5% on a constant currency basis, mainly due to market conditions, partially offset by higher levels of big box activity.
EMEA Sales Increased by 0.7% on a constant currency basis, driven by stronger volumes, favorable order timing, and expanded direct presence in Germany.
Israel Sales Declined by 21.6% on a constant currency basis, mainly due to the impact of the regional conflict during the quarter.
Gross Margin 19.6%, down from 22.9% in the prior year quarter. Adjusted gross margin was 19.7%, down from 23.8%. The decline was mainly driven by lower volumes and production, resulting in lower fixed cost absorption and unfavorable product mix, partially offset by benefits from improved production footprint and cost optimization initiatives.
Operating Expenses $32.5 million or 32.1% of revenue, compared to $36.6 million or 30.6% of revenue in the prior year quarter. Excluding certain expenses, operating expenses were 30.1% of revenue compared to 28.2% in the prior year quarter. The increase as a percentage of revenue reflects lower revenues against a relatively fixed cost base, despite progress in absolute cost reduction.
Adjusted EBITDA Loss of $6.4 million, compared to a loss of $0.1 million in the prior year quarter. The decline primarily reflects lower revenues and gross margins.
Adjusted Diluted Net Loss Per Share $0.33 on 34.7 million shares, compared to $0.14 in the prior year quarter on 35 million shares.
Net Cash Position $72.4 million as of June 30, 2025, with total cash of $75.6 million and total debt to financial institutions of $3.2 million.
Porcelain business expansion: Accelerating product development and expanding the Porcelain portfolio to capture growing market opportunities.
Zero crystalline silica products: Completed development and launch of the full zero crystalline silica collection in Australia, with plans to launch additional innovative products globally.
U.S. market: Sales declined by 17% to $49.6 million due to softer residential market conditions, but business with Lowe's showed double-digit growth.
Australia market: Sales declined by 18.2% due to regulatory changes (silica ban) and slower demand from high interest rates and fewer home completions.
EMEA market: Sales increased by 0.7%, driven by stronger volumes, favorable order timing, and expanded direct presence in Germany.
Canada market: Sales decreased by 12.5%, mainly due to market conditions, partially offset by higher big box activity.
Israel market: Sales declined by 21.6%, impacted by regional conflict.
Cost reductions: Initiated additional cost reductions expected to save $10 million annually, adding to $10 million already on track for 2025, totaling $55 million in annualized savings since 2022.
Production footprint: Shifted over 70% of production to a global manufacturing network, enhancing operational flexibility and competitiveness.
Transformation strategy: Focused on structural improvements, cost reductions, and operational enhancements to achieve higher profitability and scalability.
Tariff impact assessment: Evaluating U.S. tariffs (15%-25% impact on products sold in the U.S.) and considering pricing actions to balance competitiveness and margins.
Global Economic Headwinds: Continued global economic headwinds have led to a 15.6% year-over-year decline in revenue on a constant currency basis, affecting activity across all channels.
Market Conditions in the U.S.: Sales in the U.S. declined by 17%, driven by softer market conditions in the residential channel and challenges in the commercial segment.
Australian Market Challenges: Sales in Australia dropped by 18.2% due to the government silica ban, high interest rates, and fewer new home completions.
Canadian Market Conditions: Sales in Canada decreased by 12.5%, primarily due to softer market conditions, despite some offset from higher big box activity.
Regional Conflict in Israel: Sales in Israel declined by 21.6%, mainly due to the impact of regional conflict during the quarter.
Tariff Impact in the U.S.: New U.S. tariffs are expected to have a 15%-25% impact on products sold in the U.S., which represents approximately half of the company's total revenues.
Silicosis-Related Lawsuits: The company faces lawsuits involving 423 injured persons related to exposure to respirable crystalline silica dust, with a provision of $44.9 million recorded for probable exposure.
Gross Margin Decline: Gross margin dropped to 19.6% from 22.9% in the prior year, driven by lower volumes, unfavorable product mix, and lower fixed cost absorption.
Adjusted EBITDA Loss: Adjusted EBITDA showed a loss of $6.4 million compared to a loss of $0.1 million in the prior year, primarily due to lower revenues and gross margins.
Litigation and Insurance Uncertainty: Uncertainty remains regarding the scope of liability and insurance coverage for silicosis-related claims, with potential losses ranging from $0.5 million to $13 million per claim.
Cost Reduction: The company has initiated incremental cost reductions expected to bring an additional $10 million of annualized savings commencing in the second half of 2025. Combined with previous measures, total annualized cost savings since 2022 will exceed $55 million.
Porcelain Business Expansion: The company is accelerating product development and expanding its Porcelain portfolio to capture growing market opportunities. Additional innovative products are expected to launch during the remainder of 2025 and into 2026.
Zero Crystalline Silica Products: In Australia, the company has completed the development and launch of a full zero crystalline silica collection. Additional product launches are planned for other markets in 2025 and 2026.
U.S. Tariffs Impact: The company estimates a tariff impact in the range of 15% to 25% on products sold in the U.S., which represents approximately half of total revenues. The impact is expected to be more pronounced as the year progresses.
Profitability Outlook: Structural improvements, including cost reductions and operational enhancements, are expected to enable higher levels of profitability as volumes improve.
Richmond Hill Site Sale: A potential buyer has been granted the right to acquire the Richmond Hill site at a price approximating its book value. The buyer has commenced due diligence.
The selected topic was not discussed during the call.
The earnings call indicates several concerns: declining U.S. and Canadian sales, gross margin decline, and increased operating expenses. The potential tariffs and legal proceedings add uncertainty. Despite some positive developments, such as cost reduction efforts and growth in Australia and EMEA, these do not outweigh the negative impacts. The absence of Q&A also suggests limited analyst engagement or confidence. Overall, the stock is likely to experience a negative reaction due to these factors.
Despite some positive aspects, such as increased business with Lowe's and a stable EMEA region, the overall sentiment is negative. The earnings call reveals significant challenges, including declining revenues across most regions, gross margin deterioration, and increased litigation risks. The Q&A session confirmed these concerns without providing mitigating factors. Additionally, the impact of new U.S. tariffs and ongoing silicosis-related lawsuits further contribute to a negative outlook. The company's financial health is strained, as evidenced by the adjusted EBITDA loss and increased net loss per share, making a negative stock price reaction likely.
The earnings call reveals significant challenges: a substantial revenue decline, missed EPS expectations, and competitive pressures. Despite improved gross margins and cash flow, the lack of a shareholder return plan and substantial silicosis claims pose risks. Management's vague guidance and unchanged negative market dynamics further dampen sentiment. The negative outweighs the positive elements, suggesting a likely negative stock price movement.
The earnings call reflects a challenging financial environment with declining revenues, adjusted EBITDA losses, and legal risks. Despite improved margins and cost savings, the company faces pricing pressures and operational challenges. The Q&A session highlighted unclear guidance, ongoing revenue declines, and market pressures, which dampens sentiment. The absence of a positive catalyst, like a partnership announcement, combined with negative trends suggests a negative stock price reaction over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.